A Phase 2 Study of the Effects of 6R-BH4 in Subjects With Sickle Cell Disease

This study has been completed.

Sponsor:

Information provided by:

BioMarin Pharmaceutical

ClinicalTrials.gov Identifier:

NCT00445978

First received: March 7, 2007

Last updated: July 9, 2009

Last verified: July 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2009
Primary Completion Date:	August 2008 (Final data collection date for primary outcome measure)